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Lipid sensing and insulin signaling in the brain independently triggers a negative feedback system to lower
glucose production and food intake. Here, we discuss the underlying molecular and neuronal mechanisms
of lipid sensing and insulin signaling in the hypothalamus and how these mechanisms are affected in
response to high-fat feeding. We propose that high-fat feeding concurrently disrupts hypothalamic insulin-
signaling and lipid-sensing mechanisms and that experiments aimed to restore both insulin action and lipid
sensing in the brain could effectively lower glucose production and food intake to restore metabolic homeo-
stasis in type 2 diabetes and obesity.Introduction
The nutritional status of the body is detected by the central
nervous system, where it orchestrates and relays signals in
various brain nuclei and triggers peripheral responses to main-
tain metabolic homeostasis. These peripheral responses include
behavioral effects such as feeding, as well as fuel mobilization
and utilization or fuel storage (Morton et al., 2006; Lam, 2010).
Hepatic glucose production and food intake are the key
contributors to glucose and energy homeostasis. Dysregulation
of hepatic glucose production and feeding partly leads to fasting
hyperglycemia and energy imbalance as seen in type 2 diabetes
and obesity. It is now recognized that the brain, primarily hypo-
thalamic nuclei but also other loci in the midbrain and hindbrain,
detects nutrients and nutritionally regulated hormonal cues such
as insulin, leptin, glucagon-like peptide 1, and ghrelin to regulate
energy balance and glucose homeostasis (Wiedmer et al., 2007;
Barrera et al., 2011; Morton et al., 2006; Lam et al., 2009). In this
perspective, we will direct our focus to lipid sensing and insulin
signaling in the brain.
Insulin signaling and lipid sensing in the hypothalamus inde-
pendently triggers a negative feedback system to inhibit glucose
production and appetite (Caspi et al., 2007; Obici et al., 2002c;
Schwartz and Porte, 2005). We here discuss the underlying
molecular and neuronal mechanisms of lipid sensing and insulin
signaling in the hypothalamus and how these mechanisms
are affected in response to high-fat feeding. We propose that
high-fat feeding concurrently disrupts hypothalamic insulin sig-
naling and lipid sensing mechanisms and dysregulates glucose
production and feeding.
Lipid Sensing in the Brain
Fatty acids are used by neurons for the synthesis of membranes
and are commonly not used by the brain as a fuel. However,
short-term accumulation of fatty acid-derived molecules in the
brain has been proposed to serve as a signal of nutrient abun-
dance and trigger negative feedback systems to limit the
entering of endogenous and exogenous-derived nutrients into
circulation. Based on studies spanning a decade, a lipid-sensing646 Cell Metabolism 15, May 2, 2012 ª2012 Elsevier Inc.pathway has emerged in the brain that limits the endogenous
output of glucose into circulation by the liver (Figure 1).
Long-Chain Fatty Acyl-CoA
Short-term intracerebroventricular (third) administration of
long-chain fatty acids (LCFAs)-oleic acids into conscious, unre-
strained rats inhibits the rate of glucose production in an exper-
imental pancreatic clamp setting by which circulating insulin
levels are maintained at basal level (Obici et al., 2002b). The
experimental procedure of the pancreatic (basal insulin)-
euglycemic clamp in combination with tracer-dilution method-
ology is used to evaluate whether selective activation of central
nervous system (CNS) lipid sensing alter glucose kinetics. This
procedure enables the evaluation of steady-state changes in
the rate of glucose production and utilization in response to
experimental treatments (i.e., direct delivery of reagents into
the hypothalamus to selectively alter lipid sensing mechanisms).
Importantly, glucoregulatory hormones such as insulin are main-
tained at basal levels, and thus any detected changes in glucose
kinetics are due directly to the treatments rather than changes in
circulating glucoregulatory hormones. CNS lipid sensing is then
evaluated in the context when insulin signaling is not stimulated
in the brain. Central oleic acid is equally effectively to lower
plasma glucose levels in a nonclamp postprandial setting (Obici
et al., 2002b), suggesting that the inhibition of glucose produc-
tion induced by central oleic acid lowers plasma glucose levels.
This study is the first to support a potential metabolic impact of
CNS lipid sensing, but does the brain senses a physiological
rise in fatty acids in blood circulation to regulate glucose
homeostasis?
The mechanism by which circulating fatty acids cross the
blood-brain barrier remains elusive. The blood-brain barrier is
once thought to be impermeable to fatty acids (Pardridge and
Oldendorf, 1977) but later studies challenged this hypothesis
since systemically administered radiolabeled fatty acids incor-
porate into the brain (Miller et al., 1987; Freed et al., 1994). Circu-
lating fatty acids access the brain by passive diffusion (Hamilton
and Brunaldi, 2007) or by translocation via carrier proteins such
as CD36 and FATP1 (Mitchell et al., 2009). Upon entry into glial
Figure 1. Proposed Model of Hypothalamic
Lipid-Sensing Mechanisms
Long-chain fatty acids (LCFAs) are taken up by the
brain via CD36 or FATP1 or passive diffusion.
LCFAs are esterified by acyl-CoA synthetases
(ACSs) to LCFA-CoAs, which enter mitochondria
and undergo b oxidation via carnitine palmitoyl-
transferase-1 (CPT-1). Fatty acid oxidation is
regulated by the availability of malonyl-CoA, which
inhibits CPT-1 activity. The proposed model is that
a short-term accumulation of cytosolic LCFA-
CoAs activate PKC-d and KATP channels which
trigger neuronal transmission mediated by the
NMDA receptors in the dorsal vagal complex (DVC)
to inhibit hepatic glucose production in the pres-
ence of circulating basal insulin levels. In addition,
hypothalamic LCFA-CoA sensing mechanisms
mediate glucose-lactate metabolism to regulation
glucose production. GLUT1, glucose transporter-
1; LDH, lactate dehydrogenase.
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CoA synthetase. Direct inhibition of hypothalamic acyl-CoA
synthetase disrupts the ability of circulating fatty acids to accu-
mulate hypothalamic LCFA-CoA (Lam et al., 2005b). As such, the
inhibitory response on hepatic glycogenolysis to circulating fatty
acid-stimulated hepatic gluconeogenesis (Chu et al., 2002; Chen
et al., 1999; Lam et al., 2005b) is disrupted and leads to a dysre-
gulation of glucose production (Lam et al., 2005b). Thus, circu-
lating fatty acids are metabolized in the hypothalamus and that
subsequent accumulation of fatty acid-derived LCFA-CoA is
essential to trigger lipid-sensing mechanisms to inhibit glucose
production and maintain glucose homeostasis in rodents.
During prolonged fasting, the level of plasma free fatty acids
(Ruge et al., 2009) and the rate of hepatic glucogenogenesis
(Landau et al., 1996) increase, while plasma glucose level
remains at basal (Landau et al., 1996). Is the glucoregulatory
impact of CNS lipid sensing relevant in prolonged fasting? First,
rats undergone prolonged fasting have a significant reduction in
hypothalamic LCFA-CoA level (He et al., 2006) in spite of an
elevation of circulating fatty acid levels. Second, the relative
contribution of hepatic gluconeogenesis to glucose production
increases from 50%–90% as the duration of fasting increases
(Landau et al., 1996). We postulate that hypothalamic lipid-
sensing mechanisms are disrupted in prolonged fasting since
hypothalamic LCFA-CoA level fails to accumulate. Con-
sequently, the inhibitory effect on hepatic glycogenolysis
diminishes over time, while fatty acid-stimulated hepatic gluco-
neogenesis becomes the primary contributor to glucose pro-Cell Metabolisduction and supplier of glucose fuel for
the body. We propose that CNS lipid-
sensing mechanisms are designed to
trigger a negative feedback system to
limit endogenous nutrient output in post-




CoA Biochemical Sensory Axis
Carnitine palmitoyltransferase-1 (CPT-1)
regulates the entry of LCFA-CoA intomitochondria for b oxidation (Caspi et al., 2007). Inhibition of
hypothalamic CPT-1 elevates LCFA-CoA and inhibits glucose
production in the presence of basal plasma insulin levels (Obici
et al., 2003). The liver isoform of CPT-1, CPT-1a, is prevalent in
the hypothalamus and the isoform that modifies glucose produc-
tion (Obici et al., 2003). The brain-specific CPT-1 isoformCPT-1c
(Price et al., 2002) is also expressed in the hypothalamic
arcuate nucleus (Wolfgang et al., 2006) and implicated in the
regulation of energy balance (Lane et al., 2008; Gao et al.,
2011a; Wolfgang and Lane, 2011). The relative contribution of
hypothalamic CPT-1c versus CPT-1a in glucose regulation
remains to be assessed.
CPT-1 activity is endogenously inhibited by malonyl-CoA
(McGarry et al., 1977; McGarry et al., 1983), and a rise in
malonyl-CoA thus concurrently elevates LCFA-CoA (Caspi
et al., 2007). Chronic reduction of hypothalamic malonyl-CoA
levels via overexpression of malonyl-CoA decarboxylase in-
duces hyperphagia and obesity (He et al., 2006; Hu et al.,
2005) and in parallel negates the ability of circulating fatty acids
to accumulate hypothalamic malonyl-CoA and LCFA-CoA levels
to regulate glucose production (He et al., 2006). Although
the relative role of hypothalamic malonyl-CoA and LCFA-CoA
remains to be clarified, a hypothalamic malonyl-CoA /
PT-1/ LCFA-CoA axis emerges to mediate CNS lipid sensing
to regulate glucose and energy homeostasis (Figure 1).
Glucose enters the glial cells and elevates pyruvate and
lactate (Bittar et al., 1996). Lactate is then shuttled into neurons
and converted back to pyruvate to form acetyl-CoA andm 15, May 2, 2012 ª2012 Elsevier Inc. 647
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Pellerin, 2010). In parallel, an enhancement of hypothalamic
glucose flux into lactate / pyruvate / acetyl-CoA formation
inhibits glucose production (Lam et al., 2005a), and plasma
glucose levels in a nonclamp postprandial setting (Lam et al.,
2005a). Given that acetyl-CoA is a precursor of malonyl-
CoA that is enzymatically derived by acetyl-CoA carboxylase
(ACC) (Lam et al., 2005c), the hypothalamic malonyl-CoA /
CPT-1/ LCFA-CoA axis is positioned to mediate CNS glucose
sensing to regulate peripheral glucose homeostasis. When
hypothalamic ACC is inhibited through the activation of AMP-
dependent protein kinase (AMPK), hypothalamic glucose and
lactate sensing fail to inhibit glucose production (Yang et al.,
2010). Conversely, inhibition of hypothalamic AMPK is sufficient
to inhibit glucose production (Yang et al., 2010). Similarly, an
enhancement of hypothalamic glucose flux into lactate and
malonyl-CoA formation inhibits food intake (Cha and Lane,
2009; Lam et al., 2009), while central administration of citrate
(activator of ACC) enhances the ability of circulating insulin to
increase hepatic glycogen synthesis (Cesquini et al., 2008).
These evidences support a potential critical role of the hypo-
thalamic malonly-CoA/ CPT-1/ LCFA-CoA sensory axis in
mediating hypothalamic lipid and glucose sensing mechanisms
to inhibit glucose production (Figure 1).
Protein Kinase C/ ATP-Sensitive Potassium Channel
If the accumulation of hypothalamic LCFA-CoA is essential to
mediate CNS lipid and glucose-sensing mechanisms, dissecting
the downstream effectors of LCFA-CoA is central to unveil novel
signaling molecules that inhibit glucose production and plasma
glucose levels. LCFA-CoA and lipid-derived metabolite diacyl-
glycerol activate isoforms of protein kinase C (PKC-d, PCK-q,
and PKC-ε) and hinder the ability of circulating insulin to inhibit
hepatic glucose production and stimulate muscle glucose
uptake (Boden et al., 2005; Lam et al., 2002; Samuel et al.,
2004; Shulman, 2000). The impact of hepatic PKC-d on hepatic
insulin action is recently confirmed in humans (Bezy et al.,
2011). In the presence of basal plasma insulin levels, hypotha-
lamic administration of PKC-activator 1-oleoyl-2-acetyl-sn-
glycerol activates hypothalamic PKC-d and inhibits glucose
production (Ross et al., 2008). Conversely, inhibition of hypotha-
lamic PKC-d negates CNS lipid sensing to inhibit glucose
production (Ross et al., 2008), supporting that activation of hypo-
thalamic PKC-d is sufficient and necessary for lipid sensing to
inhibit glucose production. Of note, hypothalamic PKC-d medi-
ates the anorectic response of amphetamine (Kuo et al., 2009)
and the ability of hypothalamic GLP-1 to alter peripheral glucose
homeostasis (Cabou et al., 2011) as well.
PKC phosphorylates and activates the pore-forming subunit
Kir6.2 of the ATP-sensitive potassium (KATP) channels in the
pancreatic b cells (Light et al., 2000) of which the same KATP
channels are expressed in hypothalamic neurons (Pocai et al.,
2005a). Activation of the hypothalamic KATP channels is suffi-
cient (Pocai et al., 2005a) and necessary for CNS lipid sensing
(Lam et al., 2005b) to inhibit glucose production. Importantly,
molecular and pharmacological inhibition of hypothalamic KATP
channels negates the ability of hypothalamic PKC activator to
lower glucose production as well (Ross et al., 2008). Thus,
a hypothalamic LCFA-CoA/ PKC-d/ KATP channels neuronal
signaling axis emerges that potentially mediate lipid sensing (and648 Cell Metabolism 15, May 2, 2012 ª2012 Elsevier Inc.highly likely glucose as well, although it remains to be tested) to
inhibit glucose production (Figure 1). This is in parallel to the fact
that hypothalamic PKC-d and KATP channel activations are
necessary for GLP-1 to regulate peripheral glucose homeostasis
(Sandoval et al., 2008; Cabou et al., 2011). Although it is crucial to
continue dissect themolecular, biochemical and neuronal mech-
anisms that underlie hypothalamic lipid sensing, it is equally
important to assess whether extraneuronal and hypothalamic
regions are necessary for hypothalamic lipid sensing to regulate
glucose homeostasis. These studies will shed lights on potential
novel signaling molecules that lower glucose levels.
A Hypothalamic-Hindbrain Neuronal Axis
The hindbrain receives neuronal projections from the hypothal-
amus to regulate feeding (Morton et al., 2006). Neurotransmis-
sion by N-methyl-D-aspartate (NMDA) receptors in the dorsal
vagal complex (DVC) of the hindbrain relay ascending signals
ignited by lipid sensing in the gut to maintain energy balance
(Badman and Flier, 2005; Coll et al., 2007; Cummings and Over-
duin, 2007; Lam, 2010). Independent of changes in food intake,
activation of NMDA receptors in the DVC is necessary for
duodenal lipid sensing (Cheung et al., 2009; Kokorovic et al.,
2011; Lam, 2010; Wang et al., 2008) and sufficient (Lam et al.,
2010) to inhibit glucose production. In a nonclamp physiological
setting, direct inhibition of DVC NMDA receptors negates the
ability of nutrient sensing mechanisms activated by refeeding
to maintain glucose homeostasis (Lam et al., 2011). These find-
ings raise the possibility that NMDA receptor activation in the
DVC is necessary for hypothalamic nutrient sensing mecha-
nisms to inhibit glucose production. When tested, direct
inhibition of DVC NMDA receptor-mediated transmission via
molecular and pharmacological approaches negates the ability
of hypothalamic lipid sensing mechanisms to inhibit glucose
production (Lam et al., 2011), while hypothalamic lipid sensing
stimulate neurons in the DVC (Pocai et al., 2005b) (Figure 1). It
remains to be assessed whether the neuronal projection from
the hypothalamus to DVC is direct or indirect through other
nuclei such as the paraventricular hypothalamus since hypotha-
lamic leucine metabolism triggers paraventricular hypothalamic
oxytocine neurons to stimulate neurons in the DVC to inhibit
food intake (Blouet et al., 2009).
The pancreatic clamp procedure that is used to evaluate the
glucoregulatory impact of the hypothalamic-hindbrain lipid-
sensing mechanisms involves the use of somatostatin to inhibit
the endogenous insulin and glucagon secretion while plasma
insulin levels are replaced at basal level. In these experimental
conditions, it is to be acknowledged that plasma glucagon level
is reduced by 30%–50%. However, direct activation of NMDA
receptors in the DVC is still equally effective to inhibit glucose
production when circulating glucagon is replaced at basal
level via exogenous intravenous glucagon infusion (T.K.T.L.,
unpublished data).
In summary, a unifying lipid sensing pathway in the hypo-
thalamus emerges that trigger a forebrain-hindbrain NMDA
receptor-dependent signaling cascade to inhibit glucoseproduc-
tion (Figure 1A). Although the physiological relevance of CNS lipid
sensing in glucose regulation remains to be clarified, it is to be
noted that in a nonclamp physiological setting, direct inhibition
of NMDA receptor in the DVC disrupts glucose homeostasis
during refeeding, and these findings support the working
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grate nutrient-sensing mechanisms to maintain glucose homeo-
stasis. In addition to being sensitive to nutrients, the brain is
insulin responsive.We next direct our focus to studies that selec-
tively evaluate the metabolic impact of insulin signaling in the
brain.
Insulin Signaling in the Brain
Insulin Receptor and Action
A rise in circulating insulin levels inhibits hepatic glucose produc-
tion and plasma glucose levels partly through direct binding to its
receptor in the liver (Cherrington, 1999) and an inhibition of
plasma free fatty acid levels (Bergman, 2007). Insulin receptors
are expressed in the brain as well and central administration of
insulin inhibits food intake (Woods et al., 1979). Conversely,
neuron-specific insulin receptor knockout mice develop hyper-
phagia and insulin intolerant (Bru¨ning et al., 2000).
Whole-body insulin resistance as seen in the neuron-specific
insulin receptor knockout mice is attributed to the inability of
a rise in circulating insulin level to inhibit glucose production as
assessed by the hyperinsulinemic-euglycemic clamp of which
somatostatin is not given (Fisher et al., 2005; Inoue et al.,
2006). These glucoregulatory data are consistent with the fact
that a relatively short-term knockdown of the hypothalamic
insulin receptor negates the inhibitory effect on glucose produc-
tion during a hyperinsuliemic-euglycemic clamp with somato-
statin infusion in rats (Obici et al., 2002a). Selective inhibition of
hypothalamic insulin receptor negates the ability of intracerebro-
ventricular (icv) insulin administration to inhibit glucose produc-
tion during the pancreatic (basal insulin) euglycemic clamps
(Obici et al., 2002c), while icv insulin is equally potent to inhibit
glucose production in mice in the same experimental conditions
(Inoue et al., 2006).
In a nonclamp basal setting, direct administration of insulin
into hypothalamus of rats leads to a marked and sustained
lowering of plasma glucose level independent of a rise in
systemic insulin level (Pocai et al., 2005a). Importantly, this
glucose-lowering effect is seen as well in dogs as intracisternally
insulin administration lowers blood glucose level (Chowers et al.,
1966). The effect in dogs is later on reproduced and expanded by
an independent group of which icv administration of insulin
causes a marked and sustained hypoglycaemia in mongrel
dogs (Agarwala et al., 1977). Strikingly, the central insulin-
induced hypoglycaemia diminishes only when the liver is re-
moved (Agarwala et al., 1977). Together, these data put forward
a working hypothesis that insulin action in the brain lowers
plasma glucose level through an inhibition of glucose production
in rats and mice, and by modulation of hepatic glucose fluxes
in dogs.
The ability of brain insulin action to regulate hepatic glucose
fluxes in mongrel dogs is evaluated in two studies (Edgerton
et al., 2006; Ramnanan et al., 2011). The first reports that a selec-
tive rise of insulin level in the head for 3 hr (versus control) fails to
lower glucose production in the presence of systemic hyperinsu-
linemia and hepatic insulin deficiency, suggesting that the direct
hepatic effect of insulin dominates the acute inhibitory effect on
glucose production (Edgerton et al., 2006). The second study
contains two sets of experiments of which the first illustrates
that icv insulin infusion (like rodents; see below) activates hypo-thalamic AKT and hepatic STAT3 signaling, as well as inhibiting
the expression of the gluconeogeneic enzymes glucose-6-
phosphatase and phosphoenolpyruvate carboxykinase (Ram-
nanan et al., 2011). However, icv insulin infusion only modestly
inhibits net hepatic glucose output in the same experimental
setting (Ramnanan et al., 2011). In the second set of experi-
ments, insulin is directly infused toward the head for 6 hr via
the arteries and elevates insulin level in the head, as well as in
the artery and jugular vein in 42 hr fasted dogs. This protocol
leads to a drop in circulating free fatty acid levels, which are
prevented by concurrent Intralipid infusion. In these experi-
mental conditions, insulin infusion toward the head inhibits the
net hepatic glucose output by 4 hr of head infusion through an
elevation of hepatic glucose uptake and glycogen synthesis,
but with no changes in gluconeogenesis and glucose production
(Ramnanan et al., 2011).
It is not the goal of this Perspective (although it is important) to
discuss in details the possible sceneries and possibilities that
underlie the discrepancies in the ability of insulin action in the
brain to modulate glucose production in the rodents on one
hand but to regulate hepatic glucose uptake (and inhibit net
hepatic glucose output) in dogs on the other hand. Rather, it
is to acknowledge that in light of the findings discussed above
as a whole, central insulin action lowers plasma glucose levels
and modulates hepatic glucose fluxes in a time-dependent
fashions in rats, mice, and dogs. Based on this common
ground, it is crucial to continue dissect the neuronal signaling
mechanisms that mediate insulin’s ability to regulate hepatic
glucose fluxes in rodents and dogs. As such, novel signaling
molecules that restore glucose production regulation and
homeostasis in diabetes and obesity will be revealed since
hypothalamic insulin resistance is a well-documented feature
in high-fat diet-induced obese rodents (see below). It remains
to be assessed whether hypothalamic insulin resistance occurs
in high fat-fed dogs.
Insulin Signaling Pathway/ KATP Channels/ Hepatic
Vagus/ STAT3 Signaling
Hypothalamic insulin activates phosphatidylinositol-3 kinase
(PI3K)-dependent signaling cascades in rats (Obici et al., 2002c)
and dogs (Ramnanan et al., 2011) to modulate hepatic glucose
fluxes. Downstream signaling effectors of hypothalamic insulin
receptor substrate-2 and AKT mediate the ability of insulin to
lower plasma glucose levels in diabetic rats (Gelling et al., 2006).
Insulin activates KATP channels in hypothalamic neurons of rats
in vitro (Spanswick et al., 2000) and in the mediobasal hypothal-
amus of rats in vivo to inhibit glucose production (Obici et al.,
2002c; Pocai et al., 2005a). Although the exact mechanism by
which the insulin-PI3K signaling cascade induces KATP channel
activation remains elusive, the hepatic vagal efferent innervation
relays the neuronal signal from the brain to the liver to inhibit
glucose production (Pocai et al., 2005a). This brain-liver axis
also mediates the ability of hypothalamic lipid sensing to inhibit
glucose production in the presence of basal insulin level (Pocai
et al., 2005b) and the ability of hypothalamic leptin action to lower
glucose production during a hyperinsulinemic-euglycemic
clamp without somatostatin infusion in rodents (German et al.,
2009). Importantly, a recent study has implicated that activation
of hypothalamic KATP channels in normal humans lowers glucose
production during the pancreatic basal insulin/glucagon clampsCell Metabolism 15, May 2, 2012 ª2012 Elsevier Inc. 649
Figure 2. Proposed Model of Hypothalamic
Insulin Signaling Pathways
Brain regions responsive to insulin include the
mediobasal hypothalamus (MBH) (arcuate
nucleus [ARC], ventromedial hypothalamus
[VMH]), lateral hypothalamus (LH), paraventricular
hypothalamus, and the ventral tegmental area
(VTA) of the midbrain. Neuronal subpopulations
responsive to insulin include ARC proopiomela-
nocortin (POMC) and neuropeptide Y (NPY)/
Agouti-related peptide AgRP neurons, VMH
steroidogenic factor 1 (SF-1) neurons, LH orexin
neurons, PVH corticotrophin-releasing hormone
(CRH) neurons, and VTA dopaminergic and cate-
cholaminergic neurons. The proposed model is
that insulin triggers signaling events in brain
regions, particularly the MBH AgRP neurons,
involving IRS1/2/ PI3K/ PIP3 to activate KATP
channels. As such, neuronal signals are trans-
mitted via the hepatic vagus to the liver to inhibit
gluconeogenesis and glucose production through




Perspective(Kishore et al., 2011). Future experiments are warranted to
address the discrepancies in the ability of the CNS to lower
glucose production in normal rodents and humans versus the
ability of the CNS to lower net hepatic glucose output via a stim-
ulation of glucose uptake and glycogen synthesis in normal dogs.
Neurons expressingNPYandAgRP in theaccurate nucleusare
targets of hypothalamic insulin action (Schwartz et al., 1992;
Ko¨nner et al., 2007). Insulin activates KATP channels and induces
membrane hyperpolarization to reduce the firing rate of AgRP
neurons (Ko¨nner et al., 2007). Knockout of insulin receptor
selectively in the AgRP neurons negates the ability of circulating
insulin to inhibit glucose production and hepatic gluconeogenic
gene expressions, as well as stimulating hepatic IL-6 and
STAT3 signaling, during a hyperinsulinemic-euglycemic clamp
with no somatostatin given in rodents (Ko¨nner et al., 2007).
Hepatic IL-6 and STAT3 signaling is central to the metabolic
control of hypothalamic insulin action since icv insulin fails to
lower glucose production in hepatic IL-6 and STAT3 knockout
mice (Inoue et al., 2006). The activation of hepatic STAT3 is
similarly postulated to mediate the ability of brain insulin action
to stimulate hepatic glycogen synthesis in dogs (Ramnanan
et al., 2011). These findings collectively indicate that insulin
signaling in the AgRP neurons of the arcuate nucleus activates
KATP channels and triggers the hepatic vagus to stimulate hepatic
IL-6 and STAT3 signaling to inhibit glucose production in rodents
(Figure 2). However, it is to be noted that the involvement of
hepatic IL-6 signaling inmediating the ability of circulating hyper-
insulinemia to inhibit glucose production remains to be clarified
since recent studies indicate that hepatocyte-specific disruption
of IL-6 signaling fails to alter the ability of hyerinsulinemic-eugly-650 Cell Metabolism 15, May 2, 2012 ª2012 Elsevier Inc.cemic clamps to lower glucose produc-
tion (Wunderlich et al., 2010)
Ventromedial Hypothalamus
and Ventral Tegmental Area
The ventromedial hypothalamus (VMH) is
insulin responsive (Spanswick et al.,
2000; Davidowa and Plagemann, 2001;Cotero and Routh, 2009). Insulin activates PIP3 formation in
genetically labeled SF-1 neurons in mice (Klo¨ckener et al.,
2011), and the VMH SF-1 neurons adjacent to the ventricle and
accurate nucleus (i.e., mediobasal VMH) exhibits the strongest
PIP3 activation (Klo¨ckener et al., 2011). Insulin-PIP3 signaling
activates KATP channels and inhibits firing of VMH SF-1 neurons
(Klo¨ckener et al., 2011). SF-1 neuron-specific deletion of insulin
receptors in high fat-fed mice negates the chronic activation of
insulin signaling in VMH SF-1 neurons, reverses obesity, and
improves glucose and insulin tolerance (Klo¨ckener et al., 2011).
In contrast, genetic deletion of PI3K signaling in VMH SF-1
neurons predisposes mice to high-fat diet-induced obesity
(Xu et al., 2010). Although studies are needed to clarify the ability
of insulin signaling in VMH SF-1 neurons to control obesity, it
would be important to evaluate whether VMH SF-1 neurons
mediates insulin action to regulate hepatic glucose fluxes
independent of changes in body weight.
Dopaminergic neurons in the midbrain ventral tegmental area
(VTA) express insulin receptors (Figlewicz et al., 2003) and IRS-2
protein (Pardini et al., 2006). VTA insulin regulates dopamine
reuptake via transcriptional control of dopamine transporters
(Figlewicz et al., 1994) and influences food-finding behavior,
food intake, and ultimately body weight (Figlewicz and Benoit,
2009). Mice with selective ablation of the insulin receptor gene
in catecholaminergic neurons of the midbrain increase food
intake and adiposity (Ko¨nner et al., 2011). The effect of insulin
action in the VTA on the regulation of hepatic glucose fluxes,
however, remains to be investigated.
In summary, these studies collectively put forward the
hypothesis that insulin signaling in hypothalamic neurons lowers
Figure 3. Proposed Model of High-Fat Diet-Induced Hypothalamic
Insulin Resistance
High-fat feeding disrupts insulin-signaling pathways in the brain that regulate
glucose and energy homeostasis. High-fat feeding is proposed to activate
hypothalamic PKC-q and/or p70 S6 kinase (S6K) and impair insulin to activate
AKT to regulate energy and glucose homeostasis. In parallel, high-fat feeding
activates hypothalamic ER stress and IKKb/NF-kB and/or JNK signaling
inflammatory pathways to impair insulin action while the role of hypothalamic
Toll-like receptors (TLR) activation and ceramide synthesis could also play an
important causative role in fat-induced hypothalamic insulin resistance.
Orange-colored boxed elements represent high-fat feeding-induced changes.
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in normal condition. The important follow-up question then
becomes whether high-fat feeding induces hypothalamic insulin
resistance.
High-Fat Feeding and CNS Insulin Resistance
High-fat feeding renders a state of nutrient excess leading to
pathophysiological conditions, such as obesity, insulin resis-
tance, and type 2 diabetes. High-fat feeding leads to hepatic
and muscle insulin resistance (Storlien et al., 1986; Wang et al.,
2001; Shulman, 2000) and, more relevant to the scope of this
Perspective, leads also to CNS insulin resistance.
Obesity impairs the transport of insulin through the blood-
brain barrier (Israel et al., 1993; Kaiyala et al., 2000), but direct
administration of insulin into the hypothalamus still fails to lower
food intake (Clegg et al., 2011) and glucose production (Ono
et al., 2008) in high fat-fed rodents. This is indicative of a direct
impairment of hypothalamic insulin signaling in obesity (Belgardt
and Bru¨ning, 2010a).
The inability of central insulin to lower food intake in response
to high-fat feeding associates with an impairment on hypotha-
lamic AKT activation (Clegg et al., 2011) that is due partly to an
activation of hypothalamic PKC-q (Benoit et al., 2009). In parallel,
high-fat feeding impairs the ability of hypothalamic insulin to
inhibit glucose production through the activation of hypotha-
lamic p70 S6 kinase (S6K) (Ono et al., 2008). S6K is phosphory-
lated by mTOR complex1 and inhibits AKT and insulin signaling
(Dann et al., 2007). Overexpression of hypothalamic S6K is
sufficient to negate the ability of central insulin to activate hypo-
thalamic AKT and inhibit glucose production, while inhibition ofhypothalamic S6K activity rescues the metabolic control of
hypothalamic insulin action (Ono et al., 2008). Based on these
observations, a working model becomes apparent that high-fat
feeding disrupts hypothalamic insulin-AKT signaling in rodents,
which in part could lead to hyperphagia and hyperglycemia.
An enhancement of endoplasmic reticulum (ER) stress and
inflammation leads to peripheral insulin resistance in obesity
(Hotamisligil, 2010). Similarly, high-fat feeding activates inflam-
matory processes in the rodent hypothalamus (De Souza et al.,
2005) and hypothalamic IKKb/NF-kB signaling inflammatory
pathway (via elevated ER stress) to negate hypothalamic insulin
action to lower food intake (Zhang et al., 2008). Importantly, acti-
vation of hypothalamic ER stress is sufficient to impair glucose
tolerance and induce hepatic insulin resistance and hypertension
(Purkayastha et al., 2011), while inhibition of CNS JNK signaling
enhances insulin sensitivity and improves glucose tolerance
upon high-fat feeding (Belgardt et al., 2010b) (Figure 3).
High-fat feeding induces hypothalamic inflammation and
insulin resistance through the activation of the Toll-like receptors
(TLRs) (Kleinridders et al., 2009), and again this phenomenon is in
analogous to peripheral insulin resistance (Shi et al., 2006). In the
peripheral tissues, fatty acid-induced ceramide biosynthesis is
dependent on upstream TLR4 signaling and IKKb activity
(Holland et al., 2011), and that increased ceramide biosynthesis
is required for TLR4-dependent insulin resistance (Holland et al.,
2011). Ceramides are derived from saturated fatty acids and
induce insulin resistance (Holland et al., 2007). Elevated biosyn-
thesis of ceramides in the periphery contributes in the pathogen-
esis of obesity and the metabolic syndrome, and decreased
circulating levels of ceramides achieved by inhibiting serine pal-
mitoyltransferase, the enzyme that catalyzes the rate-limiting
step of ceramides biosynthesis, improves the metabolic profiles
of high-fat diet-induced obese mice (Yang et al., 2009). Of note,
reduction of peripheral ceramide levels improves glucose
homeostasis by enhancing hepatic insulin sensitivity (Yang
et al., 2009).
In the hypothalamus, leptin-induced increases in malonyl-CoA
and CPT-1c inhibition lead to an inhibition of the de novo
synthesis of ceramide. The effect of ceramide synthesis appears
to mediate the anoretic effect of leptin (Gao et al., 2011b). Given
that leptin signaling (like insulin) in the hypothalamus enhances
insulin action to inhibit glucose production (German et al.,
2009), future studies are warranted to evaluate for a potential
role of hypothalamic ceramide synthesis in the pathogenesis of
hypothalamic insulin and leptin resistance.
In summary, based on studies to date, high-fat feeding
induces hypothalamic insulin resistance through mechanisms
that are shared in peripheral insulin resistance in rodents. Since
hypothalamic insulin is postulated to trigger a similar brain-liver
signaling axis in normal dogs tomodulate hepatic glucose fluxes,
it is essential to evaluate whether high-fat feeding induces hypo-
thalamic insulin resistance in dogs.
High-Fat Feeding and CNS Lipid Sensing
In the presence of basal circulating insulin level, short-term accu-
mulation of hypothalamic lipids signals through a LCFA-CoA/
PKC-d / KATP-dependent mechanism to inhibit glucose
production in normal rodents as discussed above. Does high-
fat feeding disrupt hypothalamic lipid sensing mechanisms?Cell Metabolism 15, May 2, 2012 ª2012 Elsevier Inc. 651
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PerspectiveHigh-fat feeding for 3 days disrupts the central short-term
infusion of oleic acid to accumulate hypothalamic LCFA-CoA
and inhibits food intake and glucose production in association
with a stimulation of hypothalamic CPT-1 activity in the
presence of basal circulating insulin levels (Pocai et al., 2006;
Morgan et al., 2004). Direct inhibition of hypothalamic CPT-1
rescues the ability of CNS lipid-sensing mechanisms to elevate
LCFA-CoA and inhibit glucose production and food intake
in high fat-fed rats (Pocai et al., 2006), suggesting that the
downstream signaling pathway of LCFA-CoA is intact in
response to short-term high-fat feeding. In fact, direct activation
of hypothalamic PKC-d is equally potent to inhibit glucose
production in the same short-term high fat-fed rats (Ross et al.,
2008).
Of note, the hypothalamic malonyl-CoA/ CPT-1/ LCFA-
CoA axis mediates glucose and lactate sensing to inhibit glucose
production in normal rodents. So, can direct enhancement of
central lactate metabolism overcome LCFA sensing defects in
high-fat feeding? Although the answer remains unknown, central
administration of lactate is equally potent to lower glucose
production in high fat-fed rats, as well as in uncontrolled diabetic
rats in a nonclamp setting (Chari et al., 2008). Future studies are
necessary to finely dissect the underlying nutrient-sensing
mechanisms that regulate peripheral metabolic homeostasis in
normal, diabetic, and obese conditions.
High-fat feeding for approximately 7 weeks has been docu-
mented to elevate hypothalamic palmityl-CoA and stearoyl-
CoA (but not oleoyl-CoA) and impair the ability of central insulin
injection to lower food intake (Posey et al., 2009). In addition,
direct central administration of LCFAs on one hand lowers
food intake and glucose production (Obici et al., 2002b) and on
the other impairs the ability of central insulin and leptin action
to inhibit food intake (Kleinridders et al., 2009; Milanski et al.,
2009). The impact of short-term versus long-term effects of
high-fat feeding on the accumulation of hypothalamic LCFA-
CoAs and the ability of hypothalamic LCFA-CoAs to regulate
peripheral glucose homeostasis under basal and insulin-stimu-
lated conditions remain to be clarified.
Conclusion
In type 2 diabetes and obesity, a dysregulation of hepatic
glucose production and feeding leads to a disruption in meta-
bolic homeostasis. Independent lipid-sensing (Figure 1) and
insulin-signaling (Figure 2) pathways in the hypothalamus are
proposed to relay signals to various brain nuclei and trigger
a brain-liver axis to inhibit glucose production in normal
conditions.
High-fat feeding concurrently disrupts hypothalamic insulin-
signaling (Figure 3) and lipid-sensing mechanisms at various
sites that led to a breakdown of metabolic homeostasis.
Importantly, studies that aimed to restore hypothalamic insulin
signaling and lipid sensing are able to partly restore glucose
and energy homeostasis in diabetes and obesity. As new studies
emerge that evaluate the impact on peripheral nutrient metabo-
lism when cellular and neuronal nutrient sensing and hormonal
signaling pathways are manipulated, new knowledge will be
gained with the hope that information can be integrated across
mammals such that better medicine can be derived for diabetes
and obesity.652 Cell Metabolism 15, May 2, 2012 ª2012 Elsevier Inc.ACKNOWLEDGMENTS
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